European Medicines Agency approves the two antibody cocktails named Ronapreve made by Roche and Regeneron, and Regkirona made by Celltrion to treat severe COVID-19 patients
The European Medicines Agency approves the two antibody cocktails named Ronapreve made by Roche and Regeneron, and Regkirona made by Celltrion to treat severe COVID-19 patients.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthEuropean Medicines Agency approves the two antibody cocktails named Ronapreve made by Roche and Regeneron, and Regkirona made by Celltrion to treat severe COVID-19 patients
View Premium plansBrowse free archive reportsThe European Medicines Agency approves the two antibody cocktails named Ronapreve made by Roche and Regeneron, and Regkirona made by Celltrion to treat severe COVID-19 patients.